We are live on ! Find out more
RT

Robert Torray Torray Investment Partners

AUM $741M
1-Year Est. Return 26.16%
 

Robert Torray is the founder of Torray, a long-standing value-oriented investment firm. Torray strategies have historically emphasized careful stock selection, margin of safety, and multi-year holding periods. The firm remains part of the classic U.S. value-manager set tracked through public disclosures.

This Fund
S&P 500
This Quarter Est. Return
+11.97%
1 Year Est. Return
+26.16%
3 Year Est. Return
+82.37%
5 Year Est. Return
+102.19%
10 Year Est. Return
+343.59%
AUM
$618M
AUM Growth
+$51.1M
Cap. Flow
-$10M
Cap. Flow %
-1.62%
Top 10 Hldgs %
30.16%
Holding
97
New
3
Increased
52
Reduced
26
Closed
3

Top Sells

Rank Stock Value
1
GM icon
General Motors
GM
+$8.64M
2
IDXX icon
Idexx Laboratories
IDXX
+$4.23M
3
COO icon
Cooper Companies
COO
+$3.91M
4
CCI icon
Crown Castle
CCI
+$3.42M
5
TROW icon
T. Rowe Price
TROW
+$3.08M

Sector Composition

Rank Sector Weight
1 Technology 25.07%
2 Financials 20.11%
3 Healthcare 13.3%
4 Industrials 11.7%
5 Consumer Discretionary 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.22T
$25.3M 4.09%
180,997
+389
+0.2% +$52.3K
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.06T
$22.9M 3.7%
64,106
FISV
3
Fiserv Inc
FISV
$28B
$20.2M 3.27%
152,378
+528
+0.3% +$64.8K
PSX icon
4
Phillips 66
PSX
$96.9B
$18.6M 3.01%
139,741
-1,010
-0.7% -$121K
JPM icon
5
JPMorgan Chase
JPM
$935B
$17.3M 2.8%
101,820
-339
-0.3% -$51.4K
HD icon
6
Home Depot
HD
$335B
$17M 2.76%
49,151
-243
-0.5% -$75.3K
ETN icon
7
Eaton
ETN
$163B
$16.9M 2.73%
69,976
MRSH
8
Marsh
MRSH
$91.6B
$16.5M 2.67%
87,022
QCOM icon
9
Qualcomm
QCOM
$169B
$16M 2.59%
110,700
-578
-0.5% -$71.6K
MSFT icon
10
Microsoft
MSFT
$3.59T
$15.8M 2.55%
41,885
+479
+1% +$170K
LEN.B icon
11
Lennar Class B
LEN.B
$20.6B
$14.7M 2.38%
115,330
GD icon
12
General Dynamics
GD
$104B
$14.6M 2.36%
56,115
+63
+0.1% +$15.4K
RPRX icon
13
Royalty Pharma
RPRX
$27.3B
$14.2M 2.3%
505,740
+93,107
+23% +$2.56M
EOG icon
14
EOG Resources
EOG
$80.3B
$14.2M 2.29%
117,074
-986
-0.8% -$123K
UNH icon
15
UnitedHealth
UNH
$350B
$14.1M 2.29%
26,852
+29
+0.1% +$15.5K
AXP icon
16
American Express
AXP
$227B
$13.9M 2.25%
74,201
JNJ icon
17
Johnson & Johnson
JNJ
$651B
$13.7M 2.22%
87,362
+10,472
+14% +$1.61M
AAPL icon
18
Apple
AAPL
$4.51T
$13M 2.1%
67,337
+1,796
+3% +$332K
AMZN icon
19
Amazon
AMZN
$2.79T
$12.8M 2.07%
84,322
+593
+0.7% +$83.1K
AMAT icon
20
Applied Materials
AMAT
$391B
$12.3M 2%
76,100
+86
+0.1% +$12.6K
HON icon
21
Honeywell
HON
$68.4B
$12.3M 1.99%
62,289
+201
+0.3% +$36.2K
CB icon
22
Chubb
CB
$132B
$12.1M 1.95%
53,427
+70
+0.1% +$15.3K
WRB icon
23
W.R. Berkley
WRB
$25.5B
$11.5M 1.86%
243,368
TXN icon
24
Texas Instruments
TXN
$241B
$11.3M 1.83%
66,344
MO icon
25
Altria Group
MO
$110B
$11M 1.79%
273,523
-41,282
-13% -$1.71M

Similar funds

Robert Torray's Q4 2023 Portfolio in Review

As of Q4 2023, Robert Torray held 97 positions worth $618M, up 9% from $567M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Robert Torray's Q4 2023 filing shows 3 new, 52 increased, 26 reduced and 3 closed positions. Its largest new stake was Vertex Pharmaceuticals: 14,068 shares worth $5.72M. The largest sale was General Motors, an estimated $8.64M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Robert Torray's largest Q4 2023 buy was Vertex Pharmaceuticals: 14,068 shares worth $5.72M.
  • Robert Torray added most to American Tower in Q4 2023, an estimated $3.56M increase.
  • Robert Torray's biggest Q4 2023 reduction was Idexx Laboratories, cutting an estimated $4.23M.
  • Robert Torray fully exited General Motors in Q4 2023, selling an estimated $8.64M.
  • Robert Torray's ten largest holdings make up 30% of its $618M portfolio in Q4 2023.
  • Robert Torray opened 3 new positions and closed 3 in Q4 2023.
  • Robert Torray's portfolio value rose 9% quarter-over-quarter to $618M.

Based on Torray Investment Partners's 13F filing for Q4 2023, filed 8 Feb 2024.